GHP Investment Advisors’s St Jude Medical STJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-13,904
Closed -$1.11M 304
2016
Q4
$1.11M Buy
13,904
+846
+6% +$67.1K 0.21% 139
2016
Q3
$1.04M Buy
13,058
+220
+2% +$17.8K 0.21% 135
2016
Q2
$1M Buy
12,838
+294
+2% +$21K 0.22% 133
2016
Q1
$690K Sell
12,544
-205
-2% -$11.2K 0.16% 170
2015
Q4
$788K Sell
12,749
-217
-2% -$13.7K 0.19% 146
2015
Q3
$818K Buy
12,966
+424
+3% +$30.3K 0.21% 135
2015
Q2
$927K Buy
12,542
+173
+1% +$12.5K 0.23% 125
2015
Q1
$809K Sell
12,369
-326
-3% -$21.7K 0.21% 133
2014
Q4
$826K Sell
12,695
-357
-3% -$23K 0.23% 122
2014
Q3
$785K Sell
13,052
-156
-1% -$10.2K 0.23% 116
2014
Q2
$915K Buy
13,208
+3
+0% +$194 0.27% 102
2014
Q1
$863K Buy
13,205
+274
+2% +$17.8K 0.28% 97
2013
Q4
$801K Buy
12,931
+3
+0% +$174 0.26% 105
2013
Q3
$693K Buy
12,928
+570
+5% +$29.4K 0.25% 105
2013
Q2
$564K Buy
+12,358
New +$536K 0.23% 116

Other funds holding STJ

GHP Investment Advisors's STJ Position: Q1 2017 in Review

GHP Investment Advisors sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 13,904 shares — an estimated $1.11M sold.

GHP Investment Advisors first reported a position in STJ in Q2 2013 and held it in 15 quarters. The position peaked at $1.11M in Q4 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • GHP Investment Advisors reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • GHP Investment Advisors sold 13,904 St Jude Medical shares in Q1 2017, an estimated $1.11M.
  • GHP Investment Advisors first reported a position in St Jude Medical in Q2 2013 and held it in 15 quarters.
  • GHP Investment Advisors's St Jude Medical position peaked at $1.11M in Q4 2016.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on GHP Investment Advisors's 13F filing for Q1 2017, filed 9 May 2017.